5 Pharmaceutical and biological preparations and substances, namely, preparations; Pharmaceutical preparations, namely, nucleic acid therapeutics and delivery vehicles being RNA and DNA therapeutics for scientific, research, medical, or pharmaceutical use; Pharmaceutical preparations, namely, nucleic acid therapeutics and delivery vehicles being RNA and DNA therapeutics which constitute and encode one or more components utilized in genome editing, gene editing, genome engineering, recombineering, gene modulation, transcriptional regulation, transcriptional modulation, gene therapy or cell therapy, for scientific, research, medical, or pharmaceutical use; Human and veterinarian vaccine preparations; Vaccines; Anti-epileptic pharmaceutical preparations; Medical preparations for the treatment of cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, infectious diseases for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations in the nature nucleic acid delivery agents; Chemical and biological reagents for medical or veterinary purposes, namely, for nucleic acid therapy; Biological preparations for medical, pharmaceutical or veterinary purposes, namely, for use in connection with nucleic acid therapy; Pharmaceutical and veterinary preparations, namely, nano particles to improve delivery of plasmid DNA and messenger RNA molecules; nano particles for the delivery of pharmaceutical or veterinary agents and preparations; nano particles for drug delivery; engineered nucleic acids for delivery of therapeutic DNA or mRNA sequences to cells, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Enzymes and nucleic acid sequences for medical use, namely, for the modification of cells and RNA and DNA; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and RNA and DNA editing; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene, genome, and cellular editing, modulation, and modification for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; Enzymes, nucleic acid molecules, and compounds/agents for modifying small RNAs with targeting agents for medical use, namely, use of the modified small RNAs in the gene editing industry; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation; Drug delivery agents in the form of pharmaceutical preparations, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds directed to lipid nanoparticles for the purpose of delivering pharmaceutical preparations to specific target tissue sites; drug delivery agents in the form of pharmaceutical preparations, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds and agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations; drug delivery agents consisting of pharmaceutical preparations and therapeutic agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations for RNA, gene therapy and mRNA regulation; drug delivery agents consisting of pharmaceutical and biological preparations for medical use that facilitate the release and delivery of a wide variety of pharmaceutical preparations for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; drug delivery agents consisting of pharmaceutical preparations that facilitate the release and delivery of a wide variety of pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation; pharmaceutical preparations, namely, vaccines; Pharmaceutical preparations, lipids, lipid nanoparticles, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds/agents for medical use